Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Japan Hotel REIT, Ordinary Profit Forecast for Last Fiscal Year Revised Upward by 4%, Raises Record High Profit Forecast, Distribution Revised Upward by 230 Yen
8985 Japan Hotel REIT Investment Corporation
Guidance Update ReportJapan Hotel REIT Investment Corporation <8985> [TSE REIT] announced a revision to its performance and dividend after the market closed on January 22nd (15:30). The ordinary profit forecast for the fiscal year ending December 2025 has been revised upward 4.2%, from the previous forecast of 25.6 billion yen to 26.7 billion yen (compared to 18.2 billion yen in the previous period), increasing the growth rate from 40.5% to 46.4%, further surpassing the previous forecast of record-high profits for two consecutive terms.
Based on the upwardly revised full-year plan announced by the company, our calculation indicates that the July to December period (second half) ordinary profit is expected to increase 8.1%, from the previous forecast of 13.2 billion yen to 14.3 billion yen (compared to 10.8 billion yen in the same period of the previous year), increasing the growth rate from 22.7% to 32.6%.
In light of the strong performance, the company has increased its planned distribution for the last fiscal year from the original plan of 4830 yen to 5060 yen (compared to 3937 yen in the previous period).
Kabutan News
Guidance Update
Second Half Update
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jul - Dec, 2025 Prev | 23,188 | 15,764 | 13,299 | 13,299 | 2,609.2 | 4,830 | Aug 25, 2025 | J-GAAP |
| Jul - Dec, 2025 New | 24,083 | 16,590 | 14,376 | 14,376 | 2,820.5 | 5,060 | Jan 22, 2026 | J-GAAP |
| Revision Rate | +3.9% | +5.2% | +8.1% | +8.1% | +8.1% |
Full Year Update
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Dec, 2025 Prev | 44,669 | 30,221 | 25,666 | 26,063 | 5,113.4 | 4,830 | Aug 25, 2025 | J-GAAP |
| Dec, 2025 New | 45,564 | 31,047 | 26,743 | 27,140 | 5,324.7 | 5,060 | Jan 22, 2026 | J-GAAP |
| Revision Rate | +2.0% | +2.7% | +4.2% | +4.1% | +4.1% |
Current Period Guidance
Second Half Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jul - Dec, 2024 | 19,119 | 12,281 | 10,839 | 10,839 | 2,227.5 | 3,937 | Feb 25, 2025 | J-GAAP |
| Jul - Dec, 2025 Guidance | 24,083 | 16,590 | 14,376 | 14,376 | 2,820.5 | 5,060 | Jan 22, 2026 | J-GAAP |
| YoY | +26.0% | +35.1% | +32.6% | +32.6% | +26.6% |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Dec, 2023 | 26,574 | 15,014 | 13,135 | 13,134 | 2,909.0 | 3,015 | Feb 21, 2024 | J-GAAP |
| Dec, 2024 | 33,481 | 20,779 | 18,273 | 18,272 | 3,755.0 | 3,937 | Feb 25, 2025 | J-GAAP |
| Dec, 2025 Guidance | 45,564 | 31,047 | 26,743 | 27,140 | 5,324.7 | 5,060 | Jan 22, 2026 | J-GAAP |
| YoY | +36.1% | +49.4% | +46.4% | +48.5% | +41.8% |
Related Articles
Nikkei 225 open on the 23rd = 209 yen higher, 53,898 yen
Nikkei 225 close on the 22nd = rebound for the first time in 6 days, 914 yen higher to 53,688 yen
Members Co, Announced business forecast for the fiscal year ending March 2026, Net Income to be 930 Million Yen
Cyfuse Biomedical, Net Income Forecast for Last Fiscal Year Loss to Narrow
KITAGAWA SEIKI, Ordinary Profit Forecast for First Half Revised Upward to an Unexpected 32% Increase, Highest in Seventeen Terms, Full Year also Increased
Genky DrugStares, Ordinary Profit Forecast for First Half Revised Upward by 9%, Raises Record High Profit Forecast, Full Year also Increased
Daiwa Office Investment, 4% Decrease in Ordinary Profit for The Current Fiscal Year
TRADE WORKS, Ordinary Profit Forecast for Last Fiscal Year Revised Upward by 44%
FLIGHT SOLUTIONS, Ordinary Profit Forecast for the Fiscal Year Revised Downward by 75%
J-Holdings Corp, Ordinary Profit Forecast for Last Fiscal Year Loss Widened in Downward Revision